StopDown
eNLife Research logo
Funding · 8 July 2026eNLife Research₹6 croreAI blood biomarker platform for Alzheimer'senlife.in ↗

eNLife Research raises ₹6 crore seed funding

By · Editor ·

seedBengaluruFounded 2025
  • ENLife Research uses AI to detect Alzheimer's and neurodegenerative disorders through blood biomarkers
  • It raised ₹6 crore in seed funding led by Piper Serica VC Fund
  • The platform is tailored to Indian genetic profiles, addressing a gap in existing diagnostic models

What happened

  • eNLife Research has raised ₹6 crore in seed funding.
  • The round was led by Piper Serica VC Fund.
  • The company is developing an AI-powered blood biomarker platform for early detection of Alzheimer's and neurodegenerative disorders.
  • The platform can detect signs up to 15 years before clinical symptoms appear.
  • It screens 5-7 biomarkers including amyloid beta and abnormal tau through a blood test.
  • Results are delivered within 2-5 hours through routine diagnostic centres.
  • The company plans to expand its R&D team in Bengaluru and advance its first diagnostic assay to clinical-grade.

Why it matters

  • Existing diagnostic models are developed on Western populations and are not accurate for Indian patients due to genetic and lifestyle differences.
  • India is expected to have the fastest-growing ageing population, making early diagnosis critical.
  • Conventional methods like PET scans, MRI scans, and cerebrospinal fluid analysis are expensive, invasive, and used late.

The business

  • Its blood test screens 5-7 biomarkers including amyloid beta and abnormal tau.
  • Next-generation assays will track 25-100 biomarkers for multiple dementias and neurodegenerative disorders.
  • Results are available within 2-5 hours through routine diagnostic centres.
  • The AI engine is trained on Indian population data, tailored to Indian genetic and lifestyle risk profiles.
  • The company collaborates with IISc, NIMHANS, TIFR Hyderabad, and Centre for Brain Research (CBR) Bengaluru.
  • It was incubated at FSID, Indian Institute of Science (IISc).
  • Headquarters are in Bengaluru, and the company was founded in 2025.

The founders

Dr. Deepak Kumaran Nair

co-founder & CEO
  • Professor at Centre for Neuroscience, IISc.
  • Co-founder and CEO of eNLife Research.

Lt. Col. Jojo Jacob

co-founder
  • A veteran.

Anish Mathew

co-founder
  • Former CEO of CAMS Finserv, a CAMS Group subsidiary.

Who put in money

  • Piper Serica VC Fund lead — Piper Serica's Bharat Tech Fund is ₹800 crore and backs AI, biosciences, semiconductors, defence tech, spacetech, and cybersecurity. Its director is Rajni Agarwal.

In numbers

₹6 croreseed funding raised · 2026
5-7biomarkers screened in current test · 2026
25-100biomarkers tracked in next-gen assays · 2026
15years before symptoms detection possible · 2026
2-5 hourstime to results · 2026

What happens next

  • Expand the R&D team in Bengaluru.
  • Validate the biomarker platform.
  • Advance the first diagnostic assay from prototype to clinical-grade.
  • Begin patent filing within 9-18 months covering biomarker binders, diagnostic assays, and detection platform.

Words to know

biomarker
A biological molecule found in blood or other body fluids that indicates a normal or abnormal process, or a disease.
amyloid beta
A protein that forms plaques in the brain, associated with Alzheimer's disease.
tau
A protein that forms tangles in the brain, another hallmark of Alzheimer's disease.
seed funding
Early-stage investment to help a startup develop its product or service before generating revenue.

The numbers around it

Healthcare & Life Sciences in July 2026: 11 rounds with a disclosed amount, $87.1 million in all; the biggest was Iswarya (Rs 350 crore). Every sector this year →

Other articles talking about it

Read it as a card in the app

Terms in this story

  • Seed round: Pre-seed and seed are the first money a startup raises from outside investors. The difference is how much has been built when the cheque arrives: pre-seed backs an idea or prototype, usually with a cheque under ₹5 crore, while seed backs an early product and runs from a few crore rupees to a few million dollars.
  • Lead investor: A lead investor is the investor that sets the price and main terms of a funding round, does the deepest checks on the company and usually puts in the largest cheque. When a headline says a round was led by a fund, that fund was the first to commit and shaped the deal that others joined.

All startup news on 8 July 2026 →

Is this eNLife Research? Get your “Featured on StopDown” badge →